RX3 PHARMACEUTICALS AWARDED TWO NEW NATIONAL INSTITUTES OF HEALTH (NIH) GRANTS TOTALING $1.5 MILLION

Rx3 Pharmaceuticals, Inc., an anti-infective drug discovery company, announced that it has recently been awarded two new grants totaling $1.5 million. The two grants complement the three-year, $3 million grant the company was awarded at its inception as well as the commercial research revenues it is currently receiving.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=6053926)